Onivyde (nal-IRI)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Onivyde (nal-IRI), covering 2024-07-10 to 2026-04-01. Get the full timeline:
Most recent: Clinical Trial Update: NALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal Adenocarcinoma, Nectar Trial [Phase 2]